Literature DB >> 24211260

Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI.

C A Cuenod1, D Balvay.   

Abstract

The microvascular network formed by the capillaries supplies the tissues and permits their function. It provides a considerable surface area for exchanges between blood and tissues. All pathological conditions cause changes in the microcirculation. These changes can be used as imaging biomarkers for the diagnosis of lesions and optimisation of treatment. Among the many imaging techniques developed to study the microcirculation, the analysis of the tissue kinetics of intravenously injected contrast agents is the most widely used, either as positive enhancement for CT, T1-weighted MRI and ultrasound - dynamic contrast-enhanced-imaging (DCE-imaging) - or negative enhancement in T2*-weighted brain MRI - dynamic susceptibility contrast-MRI (DSC-MRI) -. Acquisition involves an injection of contrast agent during the acquisition of a dynamic series of images on a zone of interest. These kinetics may be analyzed visually, to define qualitative criteria, or with software using mathematical modelling, to extract quantitative physiological parameters. The results depend on the acquisition conditions (type of imaging device, imaging mode, frequency and total duration of acquisition), the type of contrast agent, the data pre-processing (motion correction, conversion of the signal into concentration) and the data analysis method. Because of these multiple choices it is necessary to understand the physiological processes involved and understand the advantages and limits of each strategy.
Copyright © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Capillary permeability; DCE-CT; DCE-MRI; Perfusion

Mesh:

Substances:

Year:  2013        PMID: 24211260     DOI: 10.1016/j.diii.2013.10.010

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  81 in total

1.  The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.

Authors:  Xian Li; Jun-Li Hu; Lai-Min Zhu; Xin-Hai Sun; Hua-Qiang Sheng; Ning Zhai; Xi-Bin Hu; Chu-Ran Sun; Bin Zhao
Journal:  Tumour Biol       Date:  2015-02-28

2.  Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.

Authors:  Chau Hung Lee; Balamurugan Vellayappan; Matthias Taupitz; Bernd Hamm; Patrick Asbach
Journal:  Eur Radiol       Date:  2019-07-01       Impact factor: 5.315

3.  Dynamic Contrast-Enhanced MRI Reveals Unique Blood-Brain Barrier Permeability Characteristics in the Hippocampus in the Normal Brain.

Authors:  J Ivanidze; M Mackay; A Hoang; J M Chi; K Cheng; C Aranow; B Volpe; B Diamond; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-07       Impact factor: 3.825

4.  Dynamic contrast-enhanced MR imaging in osteoid osteoma: relationships with clinical and CT characteristics.

Authors:  P Pottecher; E Sibileau; S Aho; B Hamze; C Parlier; J D Laredo; V Bousson
Journal:  Skeletal Radiol       Date:  2017-04-11       Impact factor: 2.199

5.  Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease.

Authors:  Tim Godel; Anja Köhn; Nicole Muschol; Moritz Kronlage; Daniel Schwarz; Jennifer Kollmer; Sabine Heiland; Martin Bendszus; Victor-Felix Mautner; Philipp Bäumer
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

6.  Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.

Authors:  Saskia Vande Perre; Loïc Duron; Audrey Milon; Asma Bekhouche; Daniel Balvay; Francois H Cornelis; Laure Fournier; Isabelle Thomassin-Naggara
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

7.  Cerebral perfusion and compensatory blood supply in patients with recent small subcortical infarcts.

Authors:  Salvatore Rudilosso; Carlos Laredo; Marco Mancosu; Nuria Moya-Planas; Yashu Zhao; Oscar Chirife; Ángel Chamorro; Xabier Urra
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-13       Impact factor: 6.200

8.  Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters.

Authors:  Francesco Mungai; Giovanni Battista Verrone; Luigi Bonasera; Eleonora Bicci; Michele Pietragalla; Cosimo Nardi; Valentina Berti; Lorenzo Nicola Mazzoni; Vittorio Miele
Journal:  Radiol Med       Date:  2021-06-28       Impact factor: 3.469

9.  Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma.

Authors:  Benjamin M Ellingson; Jingwen Yao; Catalina Raymond; David A Nathanson; Ararat Chakhoyan; Jeremy Simpson; James S Garner; Alan G Olivero; Lars U Mueller; Jordi Rodon; Elizabeth Gerstner; Timothy F Cloughesy; Patrick Y Wen
Journal:  Clin Cancer Res       Date:  2020-04-08       Impact factor: 12.531

10.  Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT.

Authors:  Huiying Gu; Paul R Territo; Scott A Persohn; Amanda A Bedwell; Kierra Eldridge; Rachael Speedy; Zhe Chen; Wei Zheng; Yansheng Du
Journal:  J Trace Elem Med Biol       Date:  2020-09-19       Impact factor: 3.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.